Affimed N.V. (AFMDQ)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Apr 7, 2026
Affimed Revenue
Affimed had revenue of 164.00K EUR in the quarter ending September 30, 2024, a decrease of -91.62%. This brings the company's revenue in the last twelve months to 5.64M, down -72.92% year-over-year. In the year 2023, Affimed had annual revenue of 13.91M, down -67.39%.
Revenue (ttm)
5.64M EUR
Revenue Growth
-72.92%
P/S Ratio
0.00
Revenue / Employee
74.17K EUR
Employees
76
Market Cap
4.92K USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 13.91M | -28.76M | -67.39% |
| Dec 31, 2022 | 42.67M | 1.12M | 2.70% |
| Dec 31, 2021 | 41.55M | 12.69M | 43.99% |
| Dec 31, 2020 | 28.86M | 7.43M | 34.66% |
| Dec 31, 2019 | 21.43M | -2.30M | -9.68% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ONE Bio | 53.91M |
| Hemagen Diagnostics | 4.04M |
| Kaleido Biosciences | 1.10M |
| Comera Life Sciences Holdings | 1.00M |
| Entia Biosciences | 265.47K |
| MetaStat | 23.30K |